UFPT · investment memo
OWN_DEMONSTRATED_PLUS_OPEX_BRIDGE
Four distinct questions, one field each. A price is not a thesis: the trigger below forces a re-underwrite and freezes further purchases — it is never an automatic sell.
A daily close below $222.34 triggers a mandatory re-underwrite and freezes further purchases. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.
Not stated. This name has no falsifiable invalidation conditions on file, so it cannot be risk-monitored. That is a gap in the research, not a clean bill of health — recorded rather than hidden.
Cause: Intuitive Surgical brings production in-house, and it is UFPT's own 10-K that names it — "the risk that our two largest customers… will not purchase the expected volume of goods… because… Intuitive Surgical SARL, our largest customer, decides to manufacture the products itself." Intuitive was 24.3% of FY2025 revenue and its dollars were flat (−0.5%) year on year. A phased insourcing over three years removes ~$146m of revenue at above-average incremental margin. On the remaining base, revenue falls to ~$460m and operating income to ~$55m; at a 10x exit on a shrinking business the equity